$128.9 Billion Central Nervous System (CNS) Therapeutic Market Analysis By Disease Type And Segment Forecasts, 2016 - 2025 - Research and Markets

DUBLIN--()--The "Central Nervous System (CNS) Therapeutic Market Analysis By Disease Type And Segment Forecasts, 2016 - 2025" report has been added to Research and Markets' offering.

The global CNS therapeutic market is expected to reach USD 128.9 billion by 2025

Rising prevalence of mental illnesses and increasing awareness regarding psychiatric disorders are driving market growth. In addition, expanding geriatric population and rising prevalence of lifestyle-associated CNS disorders are increasing global demand for CNS therapeutics.

Mental health segment accounted for the largest market share in 2016. It is expected to retain its dominance over the forecast period owing to developing therapeutic options for mental diseases such as personality disorders and binge eating disorders. This segment is followed by degenerative disorders segment. There is growing awareness regarding neurodegenerative diseases owing to increase in initiatives by government and nongovernment organizations, such as Alzheimer's and Related Disorders Society of India.

These organizations conduct awareness campaigns and conferences, such as Asia Pacific Conference of ADI at New Delhi and Kerala State Initiative on Dementia, which encourage the adoption of treatment for degenerative and mental disorders.

Cancer segment is expected to emerge as the fastest growing segment in the Central Nervous System therapeutics market. High demand for effective treatment and a large number of drugs in later phases of clinical trials are factors expected to propel the growth of the segment.

Key Topics Covered:

1 Research Methodology

2. Executive Summary

3. CNS Therapeutics Market Variables, Trends, & Scope

4. CNS Therapeutics Market: Disease Estimates & Trend Analysis

5. CNS Therapeutics Market: Regional Estimates & Trend Analysis, by Diseases

6. Competitive Landscape

  • Pfizer, Inc.
  • Biogen, Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Eli Lily
  • Merck & Co.
  • Astra Zeneca
  • Shire PLC
  • Novartis AG
  • Teva Pharmaceuticals
  • Johnson & Johnson

For more information about this report visit https://www.researchandmarkets.com/research/dqjlj2/central_nervous

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Central Nervous System Drugs